{"name":"Innovative Molecules GmbH","slug":"innovative-molecules-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNeFZoWlR2WmlUUHNPNWdyYlRxenVNczc3bzJ4YzBCRkJUZEFKTm9JcTdGU3pyczZwNV9iTDFkZE9PWWNGVkFQT3VpRmhUWjRCeVFFWF9YREZNQkZGUGVLVnNWV29wMlN1REtfOHJXVTdrYVZUZG5SY0k3QXBWaXd0UHRHYkpiZFpyRzE3T0ZJazZReWR3dzBIbXpEemdLN2FJWWV4b056RlhsVHRaMzVKajBMTVhJczh5V0lRaTNqVFZ0NkJVTEJCV0lQRmdJTlFNcC1KMVhvQ3FBYktLSjQ0eGNZdVNsTU51R1UwZ3c4bXZPbjdrZ1E?oc=5","date":"2026-01-29","type":"trial","source":"prnewswire.com","summary":"Innovative Molecules Announces Completion of Phase 1 Program and Advancement to Phase 2 for Oral Adibelivir - prnewswire.com","headline":"Innovative Molecules Announces Completion of Phase 1 Program and Advancement to Phase 2 for Oral Adibelivir","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQejJkNTVSZzNudFNmeUI5ZW9id2hRV05YYzFJVk52YmpDWVpmRmFvT3VrbFBfaFM3YkM0VlcwTU1MNV80REhsVXJ6d09oMnRkNUljYjNzVFFlVjQySWxPUmdNejk0ekNjSVdyUjVsMU9peDg0ckljWkc1Z0xxczVVLWVFcFcydFExQUE?oc=5","date":"2026-01-16","type":"pipeline","source":"Medical Marketing and Media","summary":"Rx Rundown: Nvidia, Johnson & Johnson, AbbVie and more - Medical Marketing and Media","headline":"Rx Rundown: Nvidia, Johnson & Johnson, AbbVie and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOWG52Z2t3cndZMVZNWUF3aGhRT2pGclczd3M5RGlhRjJJOXJZUHZXQk9BSDc3ZnhhSmhTRzVGaTJXY0ViM194a3lhdjZHWEs4RjJjNHpmdGFDczBVRmxXd3NtdnhZZXkyazhJMWtsekdZNTZmeUlJak1pSDNMYktWOEtZWHF1cDY3N05oRmZOQ3FsQQ?oc=5","date":"2026-01-15","type":"deal","source":"European Biotechnology Magazine","summary":"Munich’s Innovative Molecules signs €125M partnership with Alfasigma to advance HSV encephalitis antiviral - European Biotechnology Magazine","headline":"Munich’s Innovative Molecules signs €125M partnership with Alfasigma to advance HSV encephalitis antiviral","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPWkxqaExVZmpEN0VmNE9SeDJYT0ZOTVhRM2kxQXJBV3RmWGpUNElXSzg4MmpCWWZsYkpsVzhibjFTaDZjUHg4RUo1Z2dTUXFhRXZ4V1hmdlljdkNJX2lTa01WLU42RnhkWjdhN2c0M3ZkTUQyclRSNHlYSmd4dkRkdzRoNk5nRjRVNllfdl9oQWJ4SGxaVTVCeEg5Znk2TkNMWXR0NDExYzhyQmpZOUZ2cGVVWnAtUnRY?oc=5","date":"2026-01-15","type":"deal","source":"Fierce Biotech","summary":"Alfasigma pens €125M deal for injectable form of HSV treatment - Fierce Biotech","headline":"Alfasigma pens €125M deal for injectable form of HSV treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxPSEE1ODZ4dEJ2U2NxNjczaFgwRHBQd1pZenNvUjE0ME5IdHZJeUE3RHZrTUxUR1RuMnBya19PWmNHVjJJbmRkWFFjWGFHY3otbm94dVJiSS0tbWE5cFdaY281ak1IbXgxRVRjVVhwazFFbFdSNWFET3lBWDBMZHJ3UXlCLXk0VU11aUhCakZvR1M1bG5rSHYzeGdPdmVKRDU2UDU4LVdHYzdaUUc4ODNkdVduYWxDb2dUbzh0SGh6N2VTQ2t6TE9xSFQ5VzdXM0xFdGN2WmpmQ2FBYm5aZ3ptc0RSVnlHRTZSX1R1MXV0UE10cWczMC1RSTlkOHpTb3VQblZ3dUxCZnVYdDNxWXpURF8zSktoQUdFaXM0bXhET1dpUGc?oc=5","date":"2026-01-14","type":"pipeline","source":"prnewswire.com","summary":"Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis, an Ultra-Rare Disease - prnewswire.com","headline":"Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxNdGJiX1hIRnBfajZ4OUVpTXN3X1RHTUNnT1RLdUFOSGlGbHN5NjVnbll1a1h4UEVpNjNHcURnUF9xb1pVM2pwX2JVVFlnWHh6SU9LOFh3U0Zwd1FXZmxpVXpvbHZtcGRhTU14YmxudmF3azRzckJlYUpvZ2dlN2NJbTFPYkdIaTFLVHhOTTZBZWRSNlB5LTQ5UnJOeHlGeUpaVTkwNERUYi02blpuUHhPdjhBZ3p6NTRLTlNLdFZ5Slh6YVlCblhXTGdzYjNEMHMwY0ZwZDV0MDBoU3p5V1RQTnpHb1I1NUJmTGotckNWZzQwSFdTVUdYaFc4S29yWWc5Q1pnTTZib1VxLTRHSmUzbUprc0c1OEdpN2JtZzd1MUxLMm1SNDhjMERR?oc=5","date":"2025-07-07","type":"trial","source":"GlobeNewswire","summary":"Bispecific Antibody Clinical Trial Pipeline Gains Momentum: - GlobeNewswire","headline":"Bispecific Antibody Clinical Trial Pipeline Gains Momentum:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQWlByeE56czJCbE9uUXZMeW4zWDFYRndRVVVFamtiVXh5NXo2WDZiMHZyWlcwQ0ZCNE11YWRBLTB0bkZOMjhvTVE3dXBVX2lkRWVkX2FmRW8tUndaNWRHT0c5TVhTVWVsenBhaFl3Y2xSdXdZWFc0QlM4WkRISkpEbzNWckg1aFJ4bVRScXZzdmNMaUhYUUJ1UVpSMDBtYnF1aGRqYXlpQy1Qa3pLaHV4RTR4bTBtajVzWEZHallMVkRJeXZ4Z2JCTHZRcDVMR0lWNGc?oc=5","date":"2025-06-16","type":"trial","source":"PR Newswire UK","summary":"Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250 - PR Newswire UK","headline":"Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBvUFVJd3FtcGZpMUZhV0NnYjI2NzJNMVU4YW1pV05rSEtTRmc0clRFWk1paUU5UnpqdFZMZFZXcWU5MVV3cXF6UjdGOV9JdEY0UmVDbXQtSHBjZmxTV1Z0eldFR3dQRWR1dGJlbTdIS2w?oc=5","date":"2025-03-27","type":"pipeline","source":"Wiley Online Library","summary":"2 Chemical Process Development in the Pharmaceutical Industry - Wiley Online Library","headline":"2 Chemical Process Development in the Pharmaceutical Industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNamZPWTRTZDNfa1dIRTE5bHlJRWFoY1ZFWFF2NjZ4WDJMVGVQdUpaZHdpZFo0VDR3YktSM05WV2UzeVd4bWpKbE1sU0pYcE9DbzZ1NnB2RlI4V0pXSFhWQVNhQ215NWg2QXVOSlk1ZGMxc3ZWaXpKWWhra19pczMxb2RJWUs5QzV4djgtYmFHaVFwbXJNQ3diTkpEMXhaZFN6N1JKZjZn?oc=5","date":"2025-01-29","type":"pipeline","source":"BioSpace","summary":"Pharmaceutical Market Size to Surpass USD 2.82 Trillion by 2033 - BioSpace","headline":"Pharmaceutical Market Size to Surpass USD 2.82 Trillion by 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxQWTFJT3FfWGxRa29VZWFFc1lNSUszVTZGaEJaZjkxMGc4SjZrejVwYVFvdldORWNEU0FpNmtIeUdKTnhxd1R1ZmxIOC15bEllZkRkcGp4RUx6S294QlVOR2VMbGFrdmVWMWRoVV9vcmRDNjBlTkhTMnc1QmtZMWplN1pCZWdtMWFsSzBjbDBmWFl5b3A1ZjdjLVpNeTBXUmloZ1dwTjhkZGl4bU54ZzBDYmViWU1FdWF6bzNCd0wxMWpnU3hicXZsVXFxQUxFS2tvUmRUX2c0d2FrNm85bUVoVUg0cw?oc=5","date":"2024-11-05","type":"pipeline","source":"Boehringer Ingelheim","summary":"Biopharmaceuticals: large molecules, enormous potential - Boehringer Ingelheim","headline":"Biopharmaceuticals: large molecules, enormous potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPNFFvaGI5TU8wa3lOb1FON1VYY1FaUW5TazIzelZJa2tCN3ZpSzg2VlUtZ180ejNGSm1nVFd5Y05XM1dtdDltWnA2VVdtbHBCQXNvbE04bElwdnR4N3VUdjJERUNSU3MxckJjS0RiRnhsQ2Y0M0FVdGZIM19NNDdIUkxjLUJqWVZQZUoyYl9VNklKYlhBd3phQkdUV3gxMFFEa1NiSDktT2didVpZMDRNQVJ3aVpac2ZKWlpnVmlnY3psei03dlE?oc=5","date":"2023-12-07","type":"pipeline","source":"The Hearing Review","summary":"AudioCure Pharma Awarded for Therapeutic Small Molecule for Hearing Loss - The Hearing Review","headline":"AudioCure Pharma Awarded for Therapeutic Small Molecule for Hearing Loss","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxORG1YSm5peHVwc01GREVnV1YtMVRHeGdCTUlydW9jdmlIR0VTbzRnSjRoYW40SGRJOU9jU3BHeURRRnlkY2VpRldWdlE5MGQ3d3NRcmJHRkQ2VkFJb1dtUUFRWVJLZEtJalFPX1E0d3hiYVJtRGRSOFNtUkNfcnBLRWNkdTNDRXByTFpPWDV3MWNwUEZFUHNxYg?oc=5","date":"2021-06-17","type":"pipeline","source":"Research Horizons","summary":"Drug Candidate Shows ‘Potent Anti-Herpes Activity’ - Research Horizons","headline":"Drug Candidate Shows ‘Potent Anti-Herpes Activity’","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}